Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Segregation of effector mechanisms in a tumour-specific CD8+ T-cell clone correlates with CD30 expression.

Scandinavian journal of immunology - 1 Sept 2001

Sun Y, Song M, Maeurer M J, Schadendorf D

Abstract excerpt

In this study we have analyzed CD30-antigen expression in three melanoma-directed cytotoxic T lymphocyte (CTL) clones with a T helper 0 (Th0)-like cytokine secretion profile (i.e. interleukin (IL)-4, IL-5, and interferon (IFN)-gamma). We show that all CTL clones expressed high levels of CD30 upon contact with the autologous tumour cells. One CTL clone, termed A2 with a monoclonal feature was selected for further...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Transformed
Share to Clone Cells
Share to Cytotoxicity Tests, Immunologic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interferon-gamma

Share to Interleukin-4

Share to K562 Cells

Share to Ki-1 Antigen

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 11555396
DOI: 10.1046/j.1365-3083.2001.00971.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Segregation of effector mechanisms in a tumour-specific CD8+ T-cell clone correlates with CD30 expression.PMID 11555396Read ↗

IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia.Semantic proximity Read ↗

CD30—Governor of Memory T Cells?Semantic proximity Read ↗

Differential regulation by interleukin-4 and interferon-gamma of an autologous melanoma-specific cytotoxic T-cell clone and the tumor-infiltrating lymphocytes from which it was established.Semantic proximity Read ↗

Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.Semantic proximity Read ↗

Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypesSemantic proximity Read ↗

Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.Semantic proximity Read ↗

Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T-cell receptor: limiting dilution analysis of specific CTLp in peripheral blood and tumor-invaded lymph nodes of melanoma patients.Semantic proximity Read ↗

Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression.Semantic proximity Read ↗

Characterization and augmentation of CD4+ cytotoxic T cell lines against melanoma.Semantic proximity Read ↗

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients.Semantic proximity Read ↗

Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.Semantic proximity Read ↗

Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.